RAGE‐dependent signaling in microglia contributes to neuroinflammation, Aβ accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2010

• Venue

  The FASEB Journal

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1096/fj.09-139634PMID 19906677PMCID PMC3231946
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model.

  2011cited by this paper
• Transgenic AD Model Mice, Effects of Potential Anti-AD Treatments on Inflammation, and Pathology

  2011influential reference
• Stress kinases involved inTau phosphorylation in alzheimer’s disease, tauopathies and APP transgenic mice

  2009cited by this paper
• RAGE regulates BACE1 and Aβ generation via NFAT1 activation in Alzheimer's disease animal model

  2009cited by this paper
• Aβ-Dependent Inhibition of LTP in Different Intracortical Circuits of the Visual Cortex: The Role of RAGE

  2009influential reference
• Anti-RAGE and Abeta immunoglobulin levels are related to dementia level and cognitive performance.

  2009influential reference
• Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease

  2008cited by this paper
• Site-Specific Blockade of RAGE-Vd Prevents Amyloid-β Oligomer Neurotoxicity

  2008influential reference
• Receptor for Advanced Glycation End Product-Dependent Activation of p38 Mitogen-Activated Protein Kinase Contributes to Amyloid-β-Mediated Cortical Synaptic Dysfunction

  2008influential reference
• Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease.

  2008influential reference
• Cytotoxicity of Abeta1-42, RAGE23-54, and an Abeta-RAGE complex in PC-12 cells.

  2007cited by this paper
• Cytotoxicity of Aβ 1-42, RAGE23-54, and An Aβ -RAGE Complex in PC-12 Cells

  2007influential reference
• Immune cells may fend off Alzheimer disease

  2007influential reference
• A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model

  2007cited by this paper
• Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

  2007cited by this paper
• Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches.

  2007influential reference
• Relationship between the induction of RAGE cell-surface antigen and the expression of amyloid binding sites

  2007influential reference
• RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease.

  2007influential reference
• Microglia repetitively isolated from in vitro mixed glial cultures retain their initial phenotype.

  2007influential reference
• Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.

  2007cited by this paper
• Autoimmunity in Alzheimer's disease as evidenced by plasma immunoreactivity against RAGE and Abeta42: complication of diabetes.

  2006influential reference
• Inflammation, anti-inflammatory agents and Alzheimer disease: The last 12 years

  2006influential reference
• The induction of surface β-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products

  2006cited by this paper
• The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products.

  2006cited by this paper
• Autoimmunity in Alzheimers Disease as Evidenced by Plasma Immunoreactivity Against RAGE and Aβ42: Complication of Diabetes

  2006cited by this paper
• P4–427: Evaluation of pro–inflammatory factors IL–1 and IL–6 as biomarkers in Alzheimer's disease using an intranasal cytokine model

  2006cited by this paper
• Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology.

  2006cited by this paper
• Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

  2006cited by this paper
• Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.

  2005cited by this paper
• Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.

  2005influential reference
• Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.

  2005cited by this paper
• Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice

  2005cited by this paper
• Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: statistical reliability and functional correlation.

  2005cited by this paper
• Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice

  2005influential reference
• Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.

  2005cited by this paper
• P38 Activation Mediates Amyloid-β Cytotoxicity

  2005cited by this paper
• RAGE: A journey from the complications of diabetes to disorders of the nervous system – striking a fine balance between injury and repair

  2005influential reference
• Mitochondrial dysfunction and Alzheimer's disease: role of amyloid‐β peptide alcohol dehydrogenase (ABAD)

  2005cited by this paper
• P38 activation mediates amyloid-beta cytotoxicity.

  2005cited by this paper
• Dynamic Complexity of the Microglial Activation Response in Transgenic Models of Amyloid Deposition: Implications for Alzheimer Therapeutics

  2005cited by this paper
• ABAD enhances Aβ‐induced cell stress via mitochondrial dysfunction

  2005influential reference
• Overexpression of monocyte chemotactic protein-1/ CCL2 in β-amyloid precursor protein transgenic mice show accelerated diffuse β-amyloid deposition

  2005cited by this paper
• β-Amyloid-Stimulated Microglia Induce Neuron Death via Synergistic Stimulation of Tumor Necrosis Factor α and NMDA Receptors

  2005cited by this paper
• Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases

  2005cited by this paper
• Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human β-amyloid

  2005cited by this paper
• Role of inflammation in neurodegenerative diseases

  2005influential reference
• The biology of p38 kinase: a central role in inflammation.

  2005cited by this paper
• Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition.

  2005influential reference
• Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides.

  2004cited by this paper
• RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways

  2004influential reference
• Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain

  2004cited by this paper
• Overexpression of receptor of advanced glycation end products hypersensitizes cells for amyloid beta peptide-induced cell death.

  2004influential reference
• Autoimmunity in Alzheimer’s disease: increased levels of circulating IgGs binding Aβ and RAGE peptides

  2004influential reference
• Similar promotion of Aβ1-42 fibrillogenesis by native apolipoprotein E ε3 and ε4 isoforms

  2004cited by this paper
• Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway.

  2004cited by this paper
• Inflammation occurs early during the Aβ deposition process in TgCRND8 mice

  2004cited by this paper
• RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice

  2004influential reference
• RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

  2003cited by this paper
• Interleukin-1 Mediates Pathological Effects of Microglia on Tau Phosphorylation and on Synaptophysin Synthesis in Cortical Neurons through a p38-MAPK Pathway

  2003cited by this paper
• Intrathecal inflammation precedes development of Alzheimer’s disease

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

  2003cited by this paper
• Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease.

  2003cited by this paper
• P38 MAP kinase is activated at early stages in Alzheimer's disease brain.

  2003cited by this paper
• The p38 MAP kinase signaling pathway in Alzheimer's disease.

  2003cited by this paper
• Modeling Alzheimer's disease immune therapy mechanisms: Interactions of human postmortem microglia with antibody‐opsonized amyloid beta peptide

  2002cited by this paper
• Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid Deposition

  2002cited by this paper
• Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway.

  2002cited by this paper
• Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium.

  2002influential reference
• Inflammation and Alzheimer disease: The good, the bad, and the ugly

  2001influential reference
• Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.

  2001influential reference
• Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease.

  2001influential reference
• Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure

  2001cited by this paper
• Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures.

  2001influential reference
• Activation of MKK6, an upstream activator of p38, in Alzheimer's disease

  2001cited by this paper
• Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration

  2001cited by this paper
• beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1.

  2000influential reference
• Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition.

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

  1999influential reference
• p38 Kinase Is Activated in the Alzheimer's Disease Brain

  1999influential reference
• Association of microglia with amyloid plaques in brains of APP23 transgenic mice.

  1999cited by this paper
• Microglial response to amyloid plaques in APPsw transgenic mice.

  1998cited by this paper
• Amyloid- (cid:98) peptide–Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease

  1997influential reference
• Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer's disease brain.

  1997cited by this paper
• RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.

  1996influential reference
• Mechanisms of neuronal degeneration in Alzheimer's disease.

  1996influential reference
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease

  1996cited by this paper
• Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain.

  1995influential reference
• Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?

  1995cited by this paper
• Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture.

  1994influential reference
• Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A␤ to Mitochondrial Toxicity in Alzheimer's Disease

  year unknowninfluential reference
• Journal of Neuroinflammation Interleukin-1 Mediates Alzheimer and Lewy Body Pathologies

  year unknowncited by this paper

• Redox-sensitive high mobility group box 1 (HMGB1) protein is a multipotent regulator in the pathogenesis of Alzheimer's disease.

  2026cites this paper
• Glial Cells as Key Mediators in the Pathophysiology of Neurodegenerative Diseases

  2026cites this paper
• Mechanism of action and therapeutic potential of S100A8/A9 in neuroinflammation and cognitive impairment: From molecular target to clinical application (Review)

  2025cites this paper
• Pro-Oxidative and Inflammatory Actions of Extracellular Hemoglobin and Heme: Molecular Events and Implications for Alzheimer’s and Parkinson Disease

  2025influential citation
• Microglial Dysfunction and Amyloid-Beta Pathology in Alzheimer’s Disease and HIV-Associated Neurocognitive Disorders

  2025cites this paper
• Machine learning based prediction of cognitive metrics using major biomarkers in SuperAgers

  2025cites this paper
• Autophagy in alzheimer disease pathogenesis and its therapeutic values

  2025cites this paper
• Microglial activation states and their implications for Alzheimer's Disease

  2025cites this paper
• Microglial TLR4-Lyn kinase is a critical regulator of neuroinflammation, Aβ phagocytosis, neuronal damage, and cell survival in Alzheimer’s disease

  2025cites this paper
• Shortened PGLYRP1 Peptides Regulate Antitumor Activity of Cytotoxic Lymphocytes via TREM-1 Receptor: From Biology to Bioinformatics

  2025cites this paper
• Ligature-induced periodontitis in a transgenic mouse model of Alzheimer's disease dysregulates neuroinflammation, exacerbates cognitive impairment, and accelerates amyloid pathology

  2025cites this paper
• Microglia-Mediated Phagocytosis in Alzheimer’s Disease: Mechanisms, Heterogeneity, and Therapeutic Insights

  2025cites this paper
• Extracellular matrix glycation epigenetically regulates brain aging and neurodegeneration in the in vitro aged neurovascular model.

  2025cites this paper
• One new hypothesis about the ageing process of man

  2025cites this paper
• Traditional Chinese Medicine Natural Products Targeting Shared Mechanisms of T2DM and AD: Potential Therapeutic Insights

  2025cites this paper
• Pathomechanisms, genetic insights and therapeutics in diabetes-associated dementia.

  2025cites this paper
• Advanced glycation end products and human diseases

  2025cites this paper
• Minocycline Ameliorates Cognitive Impairments Without Modulating Microglial Reactivity in Sporadic Hypercholesterolemia: A Sex-Specific Analysis in Mice

  2025cites this paper
• Effect of amyloid-beta 1-40 and 1-42 peptides on the lateral diffusion and signaling of receptor for advanced glycation endproducts (RAGE).

  2025cites this paper
• RAGE signaling pathway in glioblastoma and cognitive decline: Insights into inflammatory mechanisms and therapeutic implications.

  2025cites this paper
• Amyloid β-Induced Inflammarafts in Alzheimer’s Disease

  2025cites this paper
• The impact of high-sugar diets on central nervous system disorders: mechanisms, pathogenesis, and dietary implication

  2025cites this paper
• Prematurely Aged Human Microglia Exhibit Impaired Stress Response and Defective Nucleocytoplasmic Shuttling of ALS Associated FUS

  2025cites this paper
• Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer’s Disease: A Metabolic Perspective

  2025cites this paper
• Pathogenesis and therapeutic applications of microglia receptors in Alzheimer’s disease

  2025cites this paper
• Inhibition of BET proteins modulates amyloid-beta accumulation and cognitive performance in middle-aged mice prenatally exposed to maternal immune activation

  2025cites this paper
• More than Dysbiosis: Imbalance in Humoral and Neuronal Bidirectional Crosstalk Between Gut and Brain in Alzheimer’s Disease

  2025cites this paper
• Antiglycating effects of citrus flavonoids and associated mechanisms

  2024cites this paper
• Proteomics of plasma-derived extracellular vesicles reveals S100A8 as a novel biomarker for Alzheimer's disease: A preliminary study.

  2024cites this paper
• Plasma Concentrations of High Mobility Group Box 1 Proteins and Soluble Receptors for Advanced Glycation End-Products Are Relevant Biomarkers of Cognitive Impairment in Alcohol Use Disorder: A Pilot Study

  2024cites this paper
• Frequent Alzheimer’s disease neuropathological change in patients with glioblastoma

  2024cites this paper
• Innate immune activation in neurodegenerative diseases.

  2024cites this paper
• Nexus of NFκB/VEGF/MMP9 signaling in diabetic retinopathy-linked dementia: Management by phenolic acid-enabled nanotherapeutics.

  2024cites this paper
• Receptors on Microglia.

  2024cites this paper
• From the Mind to the Spine: The Intersecting World of Alzheimer’s and Osteoporosis

  2024cites this paper
• Pivotal role of AGE-RAGE axis in brain aging with current interventions.

  2024cites this paper
• Modulation of the Receptor for Advanced Glycation End Products Pathway by Natural Polyphenols: A Therapeutic Approach to Neurodegenerative Diseases

  2024cites this paper
• Role of the Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Inflammatory Responses

  2024cites this paper
• Microglia Signaling in Health and Disease - Implications in Sex-Specific Brain Development and Plasticity.

  2024cites this paper
• The Impact of Aging on the Function of Retinal Ganglion Cells

  2023cites this paper
• Neurochemical effects of sepsis on the brain.

  2023cites this paper
• Specific serum autoantibodies predict the development and progression of Alzheimer’s disease with high accuracy

  2023cites this paper
• Failure, Success, and Future Direction of Alzheimer Drugs Targeting Amyloid‐β Cascade: Pros and Cons of Chemical and Biological Modalities

  2023cites this paper
• How brain ‘cleaners’ fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer's disease

  2023cites this paper
• Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses

  2023cites this paper
• New cyclophilin D inhibitor rescues mitochondrial and cognitive function in Alzheimer's disease.

  2023cites this paper
• Alzheimer’s genes in microglia: a risk worth investigating

  2023cites this paper
• Network pharmacology and molecular docking to study the potential molecular mechanism of Qi Fu Yin for diabetic encephalopathy

  2023cites this paper
• Receptor for advanced glycation end-products: Biological significance and imaging applications.

  2023cites this paper
• Immune Regulatory Functions of Macrophages and Microglia in Central Nervous System Diseases

  2023cites this paper
• Neurobiological Mechanisms of Cognitive Decline Correlated with Brain Aging.

  2023cites this paper
• Targeting memory loss with aspirin, a molecular mechanism perspective for future therapeutic approaches

  2023influential citation
• RAGE in circulating immune cells is fundamental for hippocampal inflammation and cognitive decline in a mouse model of latent chronic inflammation.

  2023cites this paper
• LRP1 and RAGE Genes Transporting Amyloid and Tau Protein in the Hippocampal CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival

  2023cites this paper
• Extracellular histones as damage-associated molecular patterns in neuroinflammatory responses

  2022cites this paper
• Protein degradation-associated mechanisms that are affected in Alzheimer´s disease

  2022cites this paper
• Pathogenic Role of RAGE in Tau Transmission and Memory Deficits.

  2022cites this paper
• RAGE antagonism with azeliragon improves xenograft rejection by T cells in humanized mice.

  2022cites this paper
• The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease

  2022cites this paper
• Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions

  2022cites this paper
• Microglia in Alzheimer’s Disease: a Key Player in the Transition Between Homeostasis and Pathogenesis

  2022cites this paper
• Role and therapeutic potential of RAGE signaling in neurodegeneration.

  2022cites this paper
• Contribution of hyperglycemia-induced changes in microglia to Alzheimer’s disease pathology

  2022cites this paper
• Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer's disease.

  2022cites this paper
• Biologically Active Fragment of the Receptor for Advanced Glycation End Products (RAGE) Is Able to Inhibit Oligomerization of the Beta-Amyloid

  2022cites this paper
• The Role of High Mobility Group Box 1 (HMGB1) in Neurodegeneration: A Systematic Review

  2022cites this paper
• Pathophysiology of RAGE in inflammatory diseases

  2022cites this paper
• Amyloid Beta Peptide-Mediated Alterations in Mitochondrial Dynamics and its Implications for Alzheimer's Disease.

  2022cites this paper
• Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases

  2022cites this paper
• Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease

  2022cites this paper
• The Effects of Dietary Advanced Glycation End-Products on Neurocognitive and Mental Disorders

  2022cites this paper
• An overview on microglial origin, distribution, and phenotype in Alzheimer's disease

  2022cites this paper
• Recent Advances in the Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery Systems

  2022cites this paper
• Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments

  2022cites this paper
• HMGB1 signaling pathway in diabetes-related dementia: Blood-brain barrier breakdown, brain insulin resistance, and Aβ accumulation.

  2022cites this paper
• Microglia in Alzheimer's Disease: A Favorable Cellular Target to Ameliorate Alzheimer's Pathogenesis

  2022cites this paper
• What Is the Role of Microglial Metabolism in Inflammation and Neurodegeneration?

  2022cites this paper
• Acute MDPV Binge Paradigm on Mice Emotional Behavior and Glial Signature

  2021cites this paper
• Pathology, Risk Factors, and Oxidative Damage Related to Type 2 Diabetes-Mediated Alzheimer's Disease and the Rescuing Effects of the Potent Antioxidant Anthocyanin

  2021cites this paper
• Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention

  2021cites this paper
• Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications

  2021cites this paper
• Assessment of the Level of Rage in Cells Blood-Brain Barrier in Experimental Alzheimer’s Disease

  2021cites this paper
• Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia

  2021influential citation
• CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice

  2021cites this paper
• Alzheimer’s Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Models

  2021cites this paper
• A novel hybrid protein promotes Aβ clearance and reduces inflammatory response through MerTK

  2021cites this paper
• Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline.

  2021cites this paper
• Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia

  2021cites this paper
• Therapeutic Strategies Targeting Amyloid-β Receptors and Transporters in Alzheimer’s Disease

  2021cites this paper
• Exploiting formyl peptide receptor 2 to promote microglial resolution: a new approach to Alzheimer’s disease treatment

  2021cites this paper
• Bioinformatic Annotation of Genes for Alzheimer’s Disease and Coronary Heart Disease

  2021cites this paper
• Molecular mechanisms of neurodegeneration in the entorhinal cortex that underlie its selective vulnerability during the pathogenesis of Alzheimer's disease

  2021cites this paper
• Receptor for Advanced Glycation End Products Is Involved in LPA5-Mediated Brain Damage after a Transient Ischemic Stroke

  2021cites this paper
• Microglia and Astrocytes in Alzheimer’s Disease in the Context of the Aberrant Copper Homeostasis Hypothesis

  2021cites this paper
• The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer’s Disease

  2021cites this paper
• Protective Effect of Ginkgolide B against Cognitive Impairment in Mice via Regulation of Gut Microbiota.

  2021cites this paper
• Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge

  2021cites this paper
• Pinocembrin improves cognition and protects the NVU in Alzheimer related deficits

  2021cites this paper
• Brain Structural Alterations, Diabetes Biomarkers, and Cognitive Performance in Older Adults With Dysglycemia

  2021cites this paper
• Hypercholesterolemia and 27-Hydroxycholesterol Increase S100A8 and RAGE Expression in the Brain: a Link Between Cholesterol, Alarmins, and Neurodegeneration

  2021cites this paper